Over the next few years the Human Genome Project will progress from mostly a large scale sequencing effort into one of functional genome characterization, i.e. identifying and characterizing expressed sequences and elucidating structure/function of the proteins derived from translated sequences. The characterization of the expressed sequences has primarily relied upon sequence homology with well-characterized genes (usually to common motifs of gene families or to genes from other organisms), complementation analysis and biochemical analysis of recombinant proteins. However, these efforts have been limited in their capacity to analyze and functionally characterize large numbers of genes. In order to human genes involved in DNA repair and chromosome metabolism, we have developed genetic screens utilizing both the yeast Saccharomyces cerevisiae and E. coli for the isolation of human genes that may play a role in these processes. Specifically, we have screened for human genes that prevent the growth of a yeast pol3 mutant (the gene encoding DNA polymerase d) and a checkpoint mutant RAD9 as well as genes that induce the E. coli SOS when expressed. This approach is based upon the idea that some human genes when expressed in yeast can have a dominant-negative effect on specific endpoints and/or induce the SOS response in E. coli. These genes may affect analogous genetic endpoints in humans. In a series of parallel experiments, we have begun to screen for yeast genes that can induce the E. coli SOS regulon in order to identify genes that can affect chromosome metabolism. The functional characterization of the yeast genome for DNA metabolic genes is particularly relevant given that the sequence of the yeast genome is now complete.

Agency
National Institute of Health (NIH)
Institute
National Institute of Environmental Health Sciences (NIEHS)
Type
Intramural Research (Z01)
Project #
1Z01ES065079-03
Application #
2574429
Study Section
Special Emphasis Panel (LMG)
Project Start
Project End
Budget Start
Budget End
Support Year
3
Fiscal Year
1996
Total Cost
Indirect Cost
City
State
Country
United States
Zip Code
Alessandrini, Federica; Pezzè, Laura; Menendez, Daniel et al. (2018) ETV7-Mediated DNAJC15 Repression Leads to Doxorubicin Resistance in Breast Cancer Cells. Neoplasia 20:857-870
Lowe, Julie M; Nguyen, Thuy-Ai; Grimm, Sara A et al. (2017) The novel p53 target TNFAIP8 variant 2 is increased in cancer and offsets p53-dependent tumor suppression. Cell Death Differ 24:181-191
Menendez, Daniel; Nguyen, Thuy-Ai; Snipe, Joyce et al. (2017) The Cytidine Deaminase APOBEC3 Family Is Subject to Transcriptional Regulation by p53. Mol Cancer Res 15:735-743
Menendez, Daniel; Lowe, Julie M; Snipe, Joyce et al. (2016) Ligand dependent restoration of human TLR3 signaling and death in p53 mutant cells. Oncotarget 7:61630-61642
Lacher, Sarah E; Lee, Joslynn S; Wang, Xuting et al. (2015) Beyond antioxidant genes in the ancient Nrf2 regulatory network. Free Radic Biol Med 88:452-465
Shatz, Maria; Shats, Igor; Menendez, Daniel et al. (2015) p53 amplifies Toll-like receptor 5 response in human primary and cancer cells through interaction with multiple signal transduction pathways. Oncotarget 6:16963-80
Menendez, Daniel; Shatz, Maria; Resnick, Michael A (2013) Interactions between the tumor suppressor p53 and immune responses. Curr Opin Oncol 25:85-92
Ciribilli, Yari; Monti, Paola; Bisio, Alessandra et al. (2013) Transactivation specificity is conserved among p53 family proteins and depends on a response element sequence code. Nucleic Acids Res 41:8637-53
Lion, Mattia; Bisio, Alessandra; Tebaldi, Toma et al. (2013) Interaction between p53 and estradiol pathways in transcriptional responses to chemotherapeutics. Cell Cycle 12:1211-24
Azzam, Gregory; Wang, Xuting; Bell, Douglas et al. (2013) CSF1 is a novel p53 target gene whose protein product functions in a feed-forward manner to suppress apoptosis and enhance p53-mediated growth arrest. PLoS One 8:e74297

Showing the most recent 10 out of 42 publications